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background:  Predictors of in-hospital mortality after myocardial infarction (MI) have been reported as a dichotomy: survival versus death. 
Predictors of time from admission to death have not been reported.
methods: 7,337 patients were enrolled in a prospective multi-center registry of acute MI. In-hospital mortality was classified by time from 
admission as acute (≤2 days), sub-acute (3-7 days), 8-14 days, and ≥15 days to identify factors associated with time to death in patients who died 
before discharge. Patient and MI characteristics, in-hospital interventions, and ECG findings were screened for differences in time to in-hospital 
death.
results: 352 patients (4.8%) died before discharge. Median survival was 5 days (inter-quartile range 2-12) and 41% of in-hospital deaths occurred 
after one week. Cardiac enzymes and ejection fraction were not related to time to in-hospital death, while several clinical factors were (Table). 
Previous MI, systolic blood pressure (SBP), as well as pharmacological and interventional treatments were different among the four groups. CABG was 
performed in 12% of patients dying in hospital, but was performed more frequently in those with late (≥8 days) in-hospital mortality. Total in-hospital 
CABG mortality was 5.7%.
Conclusions: Clinical risk factors for in-hospital mortality evolve over time along with acute MI. Understanding the time-dependent risk factors 
may allow for the development of new approaches to curtail the “later” in-hospital mortality.
Time to Death (days)
< or = 2
(n=91)
3-7
(n=118)
8-14
(n=71)
> or = 15
(n=72)
p-value
Median Age (years) 74 71.5 75 71.5 0.54
Male Gender (%) 63 59 58 60 0.92
ST Elevation MI (%) 64 52 38 43 0.006
Admission SBP (mmHg), (median) 109 123 127 122 0.006
Peak Troponin (ug/L), (median) 9.8 13.3 10.1 14 0.62
Primary PCI (%) 7 1 10 10 0.023
Coronary Artery Bypass Grafting (%) 3 8 24 17 <0.001
Treatment for Congestive Heart Failure (%) 25 27 37 57 <0.001
Left ventricular ejection fraction (%) 34 38 38 38 0.42
